Manufacturers/Novitium Pharma LLC

Novitium Pharma LLC

27 drugs in NADAC|27 Generic,0 Brand

View Recalls (6)

Total Drugs

27

27G / 0B

Avg Price / Unit

$0.5197

$0.08 – $1.58

Avg 7d Change

-0.36%

Across 26 drugs with changes

7d Activity

12141 flat

of 27 total drugs

Portfolio Price Trend

Monthly average NADAC price across all drugs

Drug Portfolio

27 drugs total, 27 shown

Drug Price 7d Change
PYRAZINAMIDE 500 MG TABLET
Pyrazinamide
$1.5768
per EA
-2.75%
PYRAZINAMIDE 500 MG TABLET
Pyrazinamide
$1.5768
per EA
-2.75%
PYRAZINAMIDE 500 MG TABLET
Pyrazinamide
$1.5768
per EA
-2.75%
TRIMETHOPRIM 100 MG TABLET
Trimethoprim
$1.1777
per EA
+3.23%
ESTAZOLAM 2 MG TABLET
Estazolam
$0.8245
per EA
-1.65%
ESTAZOLAM 1 MG TABLET
Estazolam
$0.7179
per EA
+7.48%
SELEGILINE HCL 5 MG CAPSULE
Selegiline Hydrochloride
$0.6333
per EA
-0.52%
SELEGILINE HCL 5 MG CAPSULE
Selegiline Hydrochloride
$0.6333
per EA
-0.52%
TRANYLCYPROMINE SULF 10 MG TAB
Tranylcypromine
$0.6280
per EA
-1.63%
FELBAMATE 600 MG/5 ML SUSP
Felbamate
$0.6020
per ML
PYRIDOSTIGMINE 60 MG/5 ML SOLN
Pyridostigmine bromide oral
$0.5696
per ML
-6.63%
CLOTRIMAZOLE 1% SOLUTION
Clotrimazole topical
$0.5183
per ML
+0.20%
FELBAMATE 600 MG/5 ML SUSP
Felbamate
$0.3535
per ML
-3.93%
FLUDROCORTISONE 0.1 MG TABLET
Fludrocortisone Acetate
$0.3201
per EA
+0.18%
FLUDROCORTISONE 0.1 MG TABLET
Fludrocortisone Acetate
$0.3201
per EA
+0.18%
LIDOCAINE HCL 4% SOLUTION
Lidocaine Hydrochloride
$0.2619
per ML
-0.22%
CHLORZOXAZONE 500 MG TABLET
Chlorzoxazone
$0.2248
per EA
+4.51%
CHLORZOXAZONE 500 MG TABLET
Chlorzoxazone
$0.2248
per EA
+4.51%
BISOPROLOL FUMARATE 10 MG TAB
Bisoprolol Fumarate
$0.1985
per EA
-0.25%
BISOPROLOL FUMARATE 10 MG TAB
Bisoprolol Fumarate
$0.1985
per EA
-0.25%
DICYCLOMINE 10 MG/5 ML SOLN
Dicyclomine Hydrochloride
$0.1780
per ML
+1.11%
BISOPROLOL FUMARATE 5 MG TAB
Bisoprolol Fumarate
$0.1434
per EA
-8.77%
BISOPROLOL FUMARATE 5 MG TAB
Bisoprolol Fumarate
$0.1434
per EA
-8.77%
TRIHEXYPHENIDYL 5 MG TABLET
TRIHEXYPHENIDYL HYDROCHLORIDE
$0.1331
per EA
+1.65%
TRIHEXYPHENIDYL 5 MG TABLET
TRIHEXYPHENIDYL HYDROCHLORIDE
$0.1331
per EA
+1.65%
TRIHEXYPHENIDYL 2 MG TABLET
TRIHEXYPHENIDYL HYDROCHLORIDE
$0.0817
per EA
+3.63%
TRIHEXYPHENIDYL 2 MG TABLET
TRIHEXYPHENIDYL HYDROCHLORIDE
$0.0817
per EA
+3.63%

FDA Recalls (6)

Recalls matched by company name. Verify current status with FDA.

D-0443-2024
Terminated
Class III

Digoxin Tablets, USP 62.5 mcg (0.0625 mg), 100-count bottles, Rx Only, Manufactured by: Novitium Pharma LLC, 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-200-10

Failed Impurities/Degradation Specifications

Initiated: 3/25/2024
D-0389-2024
Terminated
Class III

Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-201-20

Cross Contamination with Other Products:(mycophenolate mofetil).

Initiated: 3/4/2024
D-0311-2020
Terminated
Class II

Novitium Pharma Ranitidine Capsules 150 mg 500 capsules Rx Only Manufactured by: Novitium Pharma LLC 70 Lake Drive, East Windsor, New Jersey 08520 NDC 70954-001-40

CGMP Deviations: Presence of NDMA impurity detected in product.

Initiated: 10/25/2019
D-0310-2020
Terminated
Class II

Novitium Pharma Ranitidine Capsules 150 mg 60 capsules Rx Only Manufactured by: Novitium Pharma LLC 70 Lake Drive, East Windsor, New Jersey 08520 NDC 70954-001-20

CGMP Deviations: Presence of NDMA impurity detected in product.

Initiated: 10/25/2019
D-0312-2020
Terminated
Class II

Novitium Pharma Ranitidine Capsules 300 mg 30 capsules Rx Only Manufactured by: Novitium Pharma LLC 70 Lake Drive, East Windsor, New Jersey 08520 NDC 70954-002-10

CGMP Deviations: Presence of NDMA impurity detected in product.

Initiated: 10/25/2019
D-0313-2020
Terminated
Class II

Novitium Pharma Ranitidine Capsules 300 mg 100 capsules Rx Only Manufactured by: Novitium Pharma LLC 70 Lake Drive, East Windsor, New Jersey 08520 NDC 70954-002-40

CGMP Deviations: Presence of NDMA impurity detected in product.

Initiated: 10/25/2019
Novitium Pharma LLC - Manufacturer Profile | NADAC Intelligence